Rapport Therapeutics, Inc. (RAPP)

SEC filing

Rapport Therapeutics, Inc.

RAPP · CIK 2012593

4 · Jan 5, 2026 · Yeleswaram Krishnaswamy sold 2,840 shares at $30.05/share ($85,342); was granted 9,000 shares

Yeleswaram Krishnaswamy sold 2,840 shares at $30.05/share ($85,342); was granted 9,000 shares

xslF345X05/ownership.xml

xslF345X05/ownership.xmlSEC.gov

Graphics and non-inline formats (not embedded below).